National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 53828-53829 [2020-19073]
Download as PDF
<![CDATA[
53828
Federal Register / Vol. 85, No. 169 / Monday, August 31, 2020 / Notices
Dated: August 26, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020–19164 Filed 8–28–20; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the Communication
Disorders Review Committee, October
15, 2020, 08:00 a.m. to October 16, 2020,
05:00 p.m., Embassy Suites—Chevy
Chase Pavilion, 4300 Military Road NW,
Washington, DC, 20015 which was
published in the Federal Register on
January 13, 2020, 85 FR 1816.
This notice is being amended to
change the meeting location from in
person to a virtual meeting. The meeting
is closed to the public.
Dated: August 25, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–19072 Filed 8–28–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Community Influences on Health Behavior
Study Section.
Date: September 23–25, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
19:30 Aug 28, 2020
Jkt 250001
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Tasmeen Weik, DRPH,
MPH, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3141,
Bethesda, MD 20892, (301) 827–6480,
weikts@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Cardiovascular and Respiratory Sciences
AREA/REAP Review.
Date: September 25, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Xiang-Ning Li, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5112,
MSC 7854, Bethesda, MD 20892, (301) 435–
1744, lixiang@csr.nih.gov.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Lung Cellular, Molecular, and
Immunobiology Study Section.
Date: September 29–30, 2020.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: George M Barnas, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180,
MSC 7818, Bethesda, MD 20892, (301) 435–
0696, barnasg@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel PAR Panel;
Technology Development and Research for
Coronavirus Disease 2019 (COVID–19).
Date: September 29–30, 2020.
Time: 9:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Kee Forbes, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5148,
MSC 7806, Bethesda, MD 20892, (301) 272–
4865, kee.forbes@nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group Pathophysiological Basis of Mental
Disorders and Addictions Study Section
Date: September 30-October 1, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Boris P Sokolov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217A,
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
MSC 7846, Bethesda, MD 20892, (301) 408–
9115, bsokolov@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 25, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–19071 Filed 8–28–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Time-Sensitive
Obesity Prevention.
Date: September 16, 2020.
Time: 3:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, Review Branch,
Division of Extramural Activities, NIDDK,
National Institutes of Health, Room 7353,
6707 Democracy Boulevard, Bethesda, MD
20892–2542, (301) 594–8898, barnardm@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
E:\FR\FM\31AUN1.SGM
31AUN1
Federal Register / Vol. 85, No. 169 / Monday, August 31, 2020 / Notices
Dated: August 25, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–19073 Filed 8–28–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meetings
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; NIDCD
Clinical Research Center Application (P50)
Review.
Date: September 24, 2020.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, NSC,
6001 Executive Boulevard, Rockville, MD
20852, (Telephone Conference Call).
Contact Person: Shiguang Yang, DVM,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, NIDCD, NIH, 6001
Executive Blvd., Room 8349, Bethesda, MD
20892, (301) 496–8683, yangshi@
nidcd.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel, NIDCD
Clinical Trial Review.
Date: October 1, 2020.
Time: 12:00 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, NSC
Building, 6001 Executive Boulevard,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Katherine Shim, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, NIH/NIDCD, 6001
Executive Blvd., Room 8351, Bethesda, MD
20892, (301) 496–8683, katherine.shim@
nih.gov
Name of Committee: National Institute on
Deafness and Other Communication
VerDate Sep<11>2014
19:30 Aug 28, 2020
Jkt 250001
Disorders Special Emphasis Panel,
Translational Grant Review.
Date: October 7, 2020.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, NSC
Building, 6001 Executive Boulevard,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Sheo Singh, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
6001 Executive Blvd., Room 8351, Bethesda,
MD 20892, (301) 496–8683, singhs@
nidcd.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; Hearing
and Balance Application Review.
Date: October 8–9, 2020.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, NSC
Building, 6001 Executive Boulevard,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Eliane Lazar-Wesley,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Activities, 6001 Executive Boulevard, Room
8339, MSC 9670, Bethesda, MD 20892–8401,
(301) 496–8683, el6r@nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; NIDCD
Chemosensory Fellowship Review.
Date: October 14, 2020.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, NSC,
6001 Executive Boulevard, Rockville, MD
20852 (Virtual Meeting).
Contact Person: Shiguang Yang, DVM,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, NIDCD, NIH, 6001
Executive Blvd., Room 8349, Bethesda, MD
20892, (301) 496–8683, yangshi@
nidcd.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; Clinical
Trials.
Date: October 29, 2020.
Time: 12:00 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, NSC,
6001 Executive Boulevard, Rockville, MD
20852 (Telephone Conference Call).
Contact Person: Eliane Lazar-Wesley,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Activities, 6001 Executive Boulevard, Room
8339, MSC 9670, Bethesda, MD 20892–8401,
(301) 496–8683, el6r@nih.gov
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
53829
Dated: August 25, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–19070 Filed 8–28–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Library of
Medicine Board of Scientific
Counselors.
The meeting will be open to the
public as indicated below. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations should notify the
Contact Person listed below in advance
of the meeting.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for review, discussion, and evaluation of
individual intramural programs and
projects conducted by the NATIONAL
LIBRARY OF MEDICINE, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Library of
Medicine Board of Scientific Counselors.
Date: October 15–16, 2020.
Open: October 15, 2020, 11:00 a.m. to
12:15 p.m.
Agenda: Program Discussion and Senior
Investigator Report.
Place: Virtual Meeting.
Closed: October 15, 2020, 12:15 p.m. to
12:30 p.m.
Agenda: To review and evaluate personal
qualifications, performance, and competence
of individual investigators.
Open: October 15, 2020, 12:30 p.m. to 1:15
p.m.
Agenda: Senior Investigator Report
Closed: October 15, 2020, 1:15 p.m. to 1:30
p.m.
Agenda: To review and evaluate personal
qualifications, performance, and competence
of individual investigators
Open: October 15, 2020, 1:45 p.m. to 2:30
p.m.
Agenda: Senior Investigator Report
Closed: October 15, 2020, 2:30 p.m. to 2:45
p.m.
E:\FR\FM\31AUN1.SGM
31AUN1
]]>Agencies
[Federal Register Volume 85, Number 169 (Monday, August 31, 2020)]
[Notices]
[Pages 53828-53829]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-19073]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Time-Sensitive Obesity
Prevention.
Date: September 16, 2020.
Time: 3:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Michele L. Barnard, Ph.D., Scientific Review
Officer, Review Branch, Division of Extramural Activities, NIDDK,
National Institutes of Health, Room 7353, 6707 Democracy Boulevard,
Bethesda, MD 20892-2542, (301) 594-8898,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
[[Page 53829]]
Dated: August 25, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-19073 Filed 8-28-20; 8:45 am]
BILLING CODE 4140-01-P
